down arrow

Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
75.50
0.85 (1.14%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.82 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Net Sales
245.19
Other Operating Income
0.00
Total Operating income
245.19
Raw Material Cost
128.80
Purchase of Finished goods
12.14
(Increase) / Decrease In Stocks
-8.94
Employee Cost
30.09
Power Cost
0.00
Manufacturing Expenses
0.00
Selling and Distribution Expenses
0.00
Other Expenses
57.44
Total Expenditure (Excl Depreciation)
219.53
Operating Profit (PBDIT) excl Other Income
25.66
Other Income
0.30
Operating Profit (PBDIT)
25.96
Interest
10.90
Exceptional Items
0.00
Gross Profit (PBDT)
15.06
Depreciation
11.90
Profit Before Tax
3.15
Tax
-3.51
Provisions and contingencies
0.00
Profit After Tax
6.66
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
6.66
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
6.66
Equity Capital
15.83
Face Value
10.0
Reserves
0.00
Diluted Earnings per share
0.81
Operating Profit Margin (Excl OI)
10.47%
Gross Profit Margin
6.14%
PAT Margin
2.72%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is -7.77% vs -4.18% in Dec 2023

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 153.73% vs -322.61% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 350.00% vs -77.44% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 9.33% vs 6.97% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023

Compare Nine Monthly Results Of Mangalam Drugs With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
245.19
9,199.93
-8,954.74
-97.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
245.19
9,199.93
-8,954.74
-97.33%
Raw Material Cost
128.80
1,471.08
-1,342.28
-91.24%
Purchase of Finished goods
12.14
1,244.57
-1,232.43
-99.02%
(Increase) / Decrease In Stocks
-8.94
-93.01
84.07
90.39%
Employee Cost
30.09
1,989.92
-1,959.83
-98.49%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
57.44
2,225.77
-2,168.33
-97.42%
Total Expenditure (Excl Depreciation)
219.53
6,838.33
-6,618.80
-96.79%
Operating Profit (PBDIT) excl Other Income
25.66
2,361.60
-2,335.94
-98.91%
Other Income
0.30
287.35
-287.05
-99.90%
Operating Profit (PBDIT)
25.96
2,648.95
-2,622.99
-99.02%
Interest
10.90
238.94
-228.04
-95.44%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
15.06
2,410.01
-2,394.95
-99.38%
Depreciation
11.90
405.66
-393.76
-97.07%
Profit Before Tax
3.15
2,007.79
-2,004.64
-99.84%
Tax
-3.51
427.80
-431.31
-100.82%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
6.66
1,576.55
-1,569.89
-99.58%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
6.66
1,576.55
-1,569.89
-99.58%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.66
1,570.19
-1,563.53
-99.58%
Equity Capital
15.83
40.06
-24.23
-60.48%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
6.14%
26.20%
0.00
-20.06%
PAT Margin
2.72%
17.14%
0.00
-14.42%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 244.80 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -7.77% vs -4.18% in Dec 2023

Nine Monthly - Standalone Net Profit
Standalone Net Profit 6.77 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 153.73% vs -322.61% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.65 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 350.00% vs -77.44% in Dec 2023

Nine Monthly - Interest
Interest 10.90 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 9.33% vs 6.97% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.46%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023